Experimental Models in Parkinson’s Disease: Advantages and Disadvantages
Öznur Altunlu(Atatürk University), Ahmet Hacımüftüoğlu(Atatürk University), Irmak Ferah Okkay(Atatürk University), Ufuk Okkay(Atatürk University), Feyza Burul(Ağrı İbrahim Çeçen University), Esma Topatan(Atatürk University), Selma Sezen(Atatürk University), Ziadoon Al-yaqoobi(Atatürk University), Cemil Bayram(Atatürk University)
Cited by 5
Related Papers
Sildenafil treatment attenuates lung and kidney injury due to overproduction of oxidant activity in a rat model of sepsis: a biochemical and histopathological study
|Clinical & Experimental Immunology|2011|86
Syringic acid protects against thioacetamide-induced hepatic encephalopathy: Behavioral, biochemical, and molecular evidence
|Neuroscience Letters|2021|45
Hepatoprotective and neuroprotective effect of taxifolin on hepatic encephalopathy in rats
|Metabolic Brain Disease|2022|38
The role of carnitine on ovariectomy and inflammation-induced osteoporosis in rats
|Experimental Biology and Medicine|2013|34
Neuroprotective effect of bromelain in 6-hydroxydopamine induced in vitro model of Parkinson’s disease
|Molecular Biology Reports|2021|32